false
Catalog
Pain Core Curriculum Module 1: Basics of Chronic P ...
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Melissa Weimler from Yale School of Medicine presents an overview on evaluating chronic pain, clarifying its distinction from acute pain. Chronic pain, lasting over three months, can stem from genetic, epigenetic, and psychosocial factors, and encompasses nociceptive, neuropathic, and nociplastic pain.<br /><br />1. <strong>Nociceptive Pain</strong>: Linked to tissue damage, often due to injury, affecting muscles, bones, or organs. Symptoms might include sharp or aching sensations.<br /><br />2. <strong>Neuropathic Pain</strong>: Originates from nerve damage or disease, resulting in burning or tingling sensations, often linked to conditions like diabetes or nerve injuries.<br /><br />3. <strong>Nociplastic Pain</strong>: Involves complex pain processing issues, linked with conditions like fibromyalgia.<br /><br />Dr. Weimler emphasizes a biopsychosocial approach for assessing pain, involving comprehensive evaluation tools, considering factors like mental health and substance use disorders. Chronic pain can cause psychiatric disorders, necessitating integrated treatment strategies focusing on both physical and mental health elements. This ensures a holistic understanding of patient pain experiences and guides effective treatment plans. The presentation encourages healthcare professionals to utilize validated tools for assessing chronic pain and to consider the broader context in which patients experience pain.
Keywords
chronic pain
acute pain
nociceptive pain
neuropathic pain
nociplastic pain
biopsychosocial approach
pain evaluation
mental health
integrated treatment
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English